Doris Duke Charitable Foundation

One-Time Grants

The Medical Research Program awarded the following grants to support clinical research, training and infrastructure projects in sub-Saharan Africa. The grants sought to improve the effectiveness of AIDS care and treatment in low-resource areas, and originated either from the field or from the program staff's requests for individual proposals.

2006

Philippa Easterbrook, King’s College London

$85,000 over 1 year

  • Purpose:

    Support for research project to study the epidemiology and immunogenetics of Immune Reconstitution Inflammatory Syndrome, South Africa

2004

University of Cape Town Fund, Inc.

$312,428 (over three years)

  • Purpose:

    Support for staff to expand the Desmond Tutu HIV Centre’s training program for health care workers participating in clinical research on HIV/AIDS care and treatment

Yale University

$256,200 grant (over 2 years)
Co-funded by the Irene Diamond Fund and the
President’s Fund of Yale University

  • Purpose:

    Support for a component of the Sizon’qoba Project at Tugela Ferry in rural KwaZulu-Natal, South Africa, which is assessing the feasibility and cost-effectiveness of integrating antiretroviral therapy into existing tuberculosis treatment programs

2003

Johns Hopkins University

$742,000 (over 2 years)

Massachusetts General Hospital Corporation

$300,000 (over 1 year)

  • Purpose:

    Support for the construction of Phase Three of the Doris Duke Medical Research Institute at the Nelson R. Mandela School of Medicine at the University of Natal, Durban, South Africa. This funding supports the integration of the facilities built in Phases One and Two.

2002

Pangaea Global AIDS Foundation

$177,000 grant (over 1 year)

Lisa Spacek, Johns Hopkins University

$50,000 (over 1 year)

  • Purpose:

    Clinical algorithms for the treatment of HIV/AIDS in Rakai, Uganda

Massachusetts General Hospital Corporation

$1.5 million (over 2 years)

  • Purpose:

    Support for the construction of Phase One (the first building) of the Doris Duke Medical Research Institute at the Nelson R. Mandela School of Medicine at the University of Natal, Durban, South Africa, that will house the HIV Pathogenesis Program Laboratory

Bruce Walker, Philip Goulder & Hoosen Coovadia
Massachusetts General Hospital Corporation

$2.25 million grant (over 4 years)

  • Purpose:

    For the HIV Pathogenesis Program, a bilateral program between the Nelson R. Mandela School of Medicine and the Partners AIDS Research Center that seeks to enhance the research and training opportunities for young South African clinical investigators

Elizabeth Glaser Pediatric AIDS Foundation

$472,500 grant (over 1 year)

2001

Gerald Friedland, Yale University

$50,000 grant (over 1 year)
Co-funded by Irene Diamond Fund

  • Purpose:

    Pilot project study of implementing antiretroviral therapy in resource-constrained settings, Durban, South Africa

J. Brooks Jackson,
Johns Hopkins University School of Medicine

$325,000 (over 1 year)

  • Purpose:

    Pilot project of universal nevirapine access to prevent HIV mother-to-child transmission in Kampala, Uganda

Harvard Medical School

$125,000 (over 1 year)

  • Purpose:

    Purchase of a flow cytometer for use at the Nelson R. Mandela School of Medicine, University of Natal, Durban, South Africa

2000

Taha E. Taha,
Johns Hopkins University School of Public Health

$178,000 (over 1 year)

  • Purpose:

    Nevirapine/AZT at birth to reduce mother-to-child transmission of HIV in Blantyre, Malawi